Navigation Links
Mother's immunosuppressive medications not likely to put fetus at risk
Date:11/8/2013

Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

The paper is one of the first to describe risks for medications used to treat autoimmune diseases when taken during pregnancy, according to first author William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and professor of Health Policy at Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, Tenn.

"This study is important because these conditions affect nearly 4.5 million persons in the U.S., including many women of childbearing age," Cooper said. "Currently, there are almost no data to guide women who are pregnant, or planning to become pregnant, who may need to continue their medications during pregnancy."

Study authors used health plan data from Tennessee Medicaid, Kaiser Permanente Northern California and Southern California, linked with vital records and medical records. The three geographically diverse health plans collectively provide coverage for more than 8 million persons each year.

The cohort included 608 infants, including 437 with exposure during pregnancy and 171 whose mothers filled prescriptions for immunosuppressives before, but not during, pregnancy.

Women with rheumatoid and psoriatic arthritis, ankylosing spondylitis, lupus, scleroderma, and inflammatory bowel disease who filled prescriptions for immunosuppressive treatments during pregnancy were included in the study.

The drugs studied included hydroxychloroquine, tumor necrosis factor (TNF) inhibitors and other immunosuppressives such as sulfasalazine and azathioprine.

When compared with the women who had medication treatment before, but not during, pregnancy the risk ratios for adverse fetal outcomes associated with immunosuppressive use during pregnancy were not statistically significant, the authors reported.

Cooper said some of the medications in the study are relatively new and therefore haven't been extensively used in pregnancy. As use continues to expand, follow-up studies will be important to ensure that new safety signals aren't detected.

"One of the things we find in studying drug exposures in pregnancy is that, because up to 50 percent of pregnancies are unplanned, women may be taking a medication and become pregnant while still taking a potentially harmful drug," Cooper said. "Therefore, it's very important for women who have conditions that require medical treatments to talk with their providers about potential risks of medications in pregnancy."


'/>"/>

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Related medicine news :

1. Concerns about MRSA for expectant mothers may be unfounded
2. Low-Income Mothers May Overfeed Their Infants
3. Canadian teen moms run higher risk of abuse, depression than older mothers
4. Study finds that single mothers can reduce stress by playing, engaging with children
5. Study suggests poor mothers favor daughters
6. Making bad worse for expectant mothers
7. New hospital guidelines to help mothers at risk of postpartum depression
8. Lower iron levels seen in newborns of obese mothers
9. Babies Born to Obese Mothers May Have Low Iron: Study
10. Study Ties Infant Birth Weight to Mothers Breast Cancer Risk
11. Pregnant Mothers Gut Changes May Support Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... It took just several small incisions by ... relieve pressure on the nerves under Amber Walck’s scalp, and suddenly her two-year agony ... last year, her debilitating headaches began without warning. About 39 million Americans suffer ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... This past ... the Smiles for Everyone Foundation . Over 50 underserved patients were welcomed at ... , and more while celebrating the summer season. Individuals were referred to the event ...
(Date:7/17/2019)... , ... July 17, 2019 , ... ... State ( COMPA ) today announced that seven of its member Opioid Treatment ... treatment of substance abuse and hepatitis C virus (HCV) with the goal of ...
(Date:7/17/2019)... ... July 17, 2019 , ... Dr. Jonathan Zaidan, MD, FACOG, President of Women’s ... Woman Show. The show airs on Wednesday, July 17ths at 7pm. The ... Zaidan and co-host Ann Thomas discuss the challenges that women face when it comes ...
(Date:7/13/2019)... ... 12, 2019 , ... The Oncology Institute of Hope and ... at 5380 S. Rainbow Blvd., Suite 210, Las Vegas, NV 89118. It is ... equipped with state-of-the-art medical equipment plus all of the top-notch care already offered ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... ... , ... Cloudticity, a pioneer in providing HIPAA-compliant cloud solutions, ... of Business Development. , Whaley will work with healthcare organizations on finding ... a technology leader with more than 20 years of experience, he’ll also strengthen ...
(Date:7/19/2019)... ... July 19, 2019 , ... Robinson Pharma, Inc., is ... that the facilities was audited by the Safe Quality Food (SQF) Institute using an ... SQF Food Safety Code for Manufacturing, Edition 8. , The SQF Certification program is ...
(Date:7/18/2019)... ... 2019 , ... ComplianceLine, the premier provider of whistleblower hotline, ... is moving into new corporate headquarters in Charlotte to service accelerating growth in ... into the new office which will allow our expanding team of compliance professionals ...
Breaking Medicine Technology: